Shah, N.J.; Sura, S.; Shinde, R.; Shi, J.; Bupathi, M.; Vickery, D.; Perini, R.; Motzer, R.J.
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Renal Cell Carcinoma Post-Immune-Oncology and Vascular Endothelial Growth Factor Receptor Targeted Therapies. Cancers 2025, 17, 1434.
https://doi.org/10.3390/cancers17091434
AMA Style
Shah NJ, Sura S, Shinde R, Shi J, Bupathi M, Vickery D, Perini R, Motzer RJ.
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Renal Cell Carcinoma Post-Immune-Oncology and Vascular Endothelial Growth Factor Receptor Targeted Therapies. Cancers. 2025; 17(9):1434.
https://doi.org/10.3390/cancers17091434
Chicago/Turabian Style
Shah, Neil J., Sneha Sura, Reshma Shinde, Junxin Shi, Manojkumar Bupathi, Donna Vickery, Rodolfo Perini, and Robert J. Motzer.
2025. "Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Renal Cell Carcinoma Post-Immune-Oncology and Vascular Endothelial Growth Factor Receptor Targeted Therapies" Cancers 17, no. 9: 1434.
https://doi.org/10.3390/cancers17091434
APA Style
Shah, N. J., Sura, S., Shinde, R., Shi, J., Bupathi, M., Vickery, D., Perini, R., & Motzer, R. J.
(2025). Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Renal Cell Carcinoma Post-Immune-Oncology and Vascular Endothelial Growth Factor Receptor Targeted Therapies. Cancers, 17(9), 1434.
https://doi.org/10.3390/cancers17091434
